Achilles Therapeutics plc has announced the transfer of data and samples from its TRACERx Non-Small Cell Lung Cancer study and its Material Acquisition Platform (MAP) to AstraZeneca for a total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback